港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

银诺医药－Ｂ

51.150

-1.450-2.76%

成交量：34.20万

成交额：1,750.01万

市值：233.66亿

市盈率：-112.60

高：51.700

开：51.500

低：50.750

收：52.600

52周最高：74.000

52周最低：49.500

股本：4.57亿

香港流通股本：4.20亿

量比：0.91

换手率：0.08%

股息：- -

股息率：- -

每股收益(LYR):-0.454

净资产收益率：-23.27%

总资产收益率：-11.61%

市净率：26.88

市盈率(LYR):-112.60

市销率: - -

数据加载中...

总览公司新闻公告

异动解读 | 银诺医药-B上市首日盘中暴涨近289%，GLP-1减肥药赛道引爆投资热情

新股首日｜银诺医药-B首挂大幅高开逾285%，中签一手赚超10000港元

老虎资讯综合

新股首日 | 银诺医药-B(02591.HK)首挂上市早盘高开285.44% 核心产品依苏帕格鲁肽α今年1月获批上市

港股开盘｜恒指低开0.77%，科指低开1.2%！银诺医药-B首挂大幅高开逾285%

老虎资讯综合

认购5364倍超蜜雪冰城！银诺医药今天在港上市

新股定价 | 银诺医药每股定价18.68港元，公开发售超购逾5340倍、一手中签率0.5%

老虎资讯综合

港股IPO动态：今日银诺医药上市

银诺医药-B(02591)暗盘暴涨270%引市场聚焦GLP-1赛道，派格生物医药-B(02565)价值洼地增长可期

银诺医药-B(02591.HK)：香港公开发售获5341.66倍认购

银诺医药二次赴港IPO：一款减肥药可否撑起46亿估值

中国基金报

新股暗盘 | 银诺医药-B(02591.HK)暗盘收涨274.73% 每手赚10264港元

“减肥药市场新星”银诺医药-B港股暗盘涨近3倍

新股暗盘 | 银诺医药-B(02591)暗盘盘初涨265.10% 每手赚9904港元

老虎暗盘｜银诺医药-B涨超230%，中签一手赚超9800港元

老虎资讯综合

银诺医药全员抽签，中签就是吃肉

郭二侠说财

生物科技IPO冰火两重天：资本爱什么？

减肥药概念股银诺医药-B(2591.HK)据报超购5364倍，超越蜜雪集团为今年超购王第二名！认购额涉资3700亿港元

银诺医药-B(2591.HK)据报超购5364倍，为今年超购王第二名

银诺医药港股IPO，预估一手中签率1%，甲组全部需要抽签

银诺医药(2591.HK)首日孖展超购逾136倍

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02591/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"银诺医药－Ｂ","latestPrice":51.15,"timestamp":1756179287561,"preClose":52.6,"halted":0,"volume":342000,"delay":0,"floatShares":420285370,"shares":456819349,"eps":-0.4542759304875478,"marketStatus":"交易中","change":-1.45,"latestTime":"08-26 11:35:16","open":51.5,"high":51.7,"low":50.75,"amount":17500100,"amplitude":0.018061,"askPrice":51.15,"askSize":400,"bidPrice":51.1,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-0.4542759304875478,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1756180800000},"marketStatusCode":2,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":52.6,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.906267,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-11.61%","roe":"-23.27%","lyrEps":-0.454276,"volumeRatio":0.906267,"shares":456819349,"dividePrice":0,"high":51.7,"amplitude":0.018061,"preClose":52.6,"low":50.75,"week52Low":49.5,"pbRate":"26.88","week52High":74,"institutionHeld":0,"latestPrice":51.15,"committee":0.666667,"eps":-0.4542759304875478,"divideRate":0,"volume":342000,"delay":0,"ttmEps":-0.4542759304875478,"open":51.5,"prevYearClose":18.68,"prevWeekClose":53,"prevMonthClose":18.68,"prevQuarterClose":18.68,"fiveDayClose":53.85,"twentyDayClose":18.68,"sixtyDayClose":18.68,"earningDate":1756396800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2025-08-25","current":-125.916102,"percent":1,"low":-137.156472,"twenty":-128.950158,"median":-127.373977,"eighty":-126.160281,"high":-125.916102,"avg":-128.525452,"sd":3.683387,"marketCap":24028697757},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-25","current":-125.916102,"twenty":-128.950158,"median":-127.373977,"eighty":-126.160281,"marketCap":24028697757}],"updateTime":1756176987466},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1117719886","title":"异动解读 | 银诺医药-B上市首日盘中暴涨近289%，GLP-1减肥药赛道引爆投资热情","url":"https://stock-news.laohu8.com/highlight/detail?id=1117719886","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117719886?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 09:33","pubTimestamp":1755221593,"startTime":"0","endTime":"0","summary":"港股新股银诺医药-B今日在港交所主板挂牌上市，开盘即引发投资者热捧。截至上午9点30分，该股盘中大涨288.65%，展现出市场对GLP-1减肥药赛道的强烈兴趣。银诺医药-B是一家专注于代谢性疾病治疗的生物科技公司，其核心产品依苏帕格鲁肽α已于2025年1月获批上市。分析人士指出，银诺医药-B的强势上市表现，反映了资本市场对GLP-1类药物市场潜力的高度认可。此次银诺医药-B的亮眼debut，有望进一步激发投资者对该领域的关注。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2b827bbc3b346a324213f3d186e2feaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02591"],"gpt_icon":0},{"id":"1142313386","title":"新股首日｜银诺医药-B首挂大幅高开逾285%，中签一手赚超10000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142313386","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142313386?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 09:23","pubTimestamp":1755220986,"startTime":"0","endTime":"0","summary":"8月15日，银诺医药-B首挂大幅高开280%，中签一手赚超10000港元，总市值超亿港元；此前公开发售阶段获5341.66倍倍认购，一手中签率0.5%。银诺医药成立于2014年，是一家科学驱动的生物制药公司，致力于为代谢性疾病患者提供高质量药品。","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2b827bbc3b346a324213f3d186e2feaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股首日｜银诺医药-B首挂大幅高开逾285%，中签一手赚超10000港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2559322995","title":"新股首日 | 银诺医药-B(02591.HK)首挂上市 早盘高开285.44% 核心产品依苏帕格鲁肽α今年1月获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2559322995","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559322995?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 09:22","pubTimestamp":1755220935,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02591"],"gpt_icon":0},{"id":"1123068734","title":"港股开盘｜恒指低开0.77%，科指低开1.2%！银诺医药-B首挂大幅高开逾285%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123068734","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123068734?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 09:20","pubTimestamp":1755220830,"startTime":"0","endTime":"0","summary":"8月15日，恒生指数开跌0.77%，恒生科技指数开跌1.2%。京东跌2%，Q2营收同比增22.4%超预期，外卖驱动新业务收入飙升198.8%，但拖累整体盈利；网易跌超2%，游戏业务增长放缓，Q2营收同比增9.4%不及预期，净利润同比增12.5%；派格生物医药-B涨近15%，PB-119用于治疗T2DM预计将于年内获NDA批准；新琪安涨超11%，公司发盈喜，预期上半年溢利同比增长500%–600%；银诺医药-B首挂大幅高开逾285%，此前公开发售阶段获5341.66倍倍认购，一手中签率0.5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2b827bbc3b346a324213f3d186e2feaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07226","02833","HHImain","HSCEI","HSImain","HSTECH","513600","HSI","YANG","MCHmain","02591","MHImain","BK4614"],"gpt_icon":0},{"id":"2559599615","title":"认购5364倍超蜜雪冰城！银诺医药今天在港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2559599615","media":"医药魔方","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559599615?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 08:39","pubTimestamp":1755218387,"startTime":"0","endTime":"0","summary":"值得注意的是，受到港交所生科板块回暖影响，银诺医药的打新非常火爆，超额认购到5364倍，比蜜雪的5200倍还高，认购资金盘3700亿。本次IPO中，银诺医药以18.68港元/股的发行价发行36,556,400股H股，按照发行价计算市值超85亿港元。银诺医药募资总额为6.83亿港元，扣除发行费用后募资净额为6.1亿港元。截至2025年5月31日，其在中国销售依苏帕格鲁肽a产生收入人民币38.1百万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815085123a48980b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815085123a48980b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":1},{"id":"1142397652","title":"新股定价 | 银诺医药每股定价18.68港元，公开发售超购逾5340倍、一手中签率0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142397652","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142397652?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 07:57","pubTimestamp":1755215838,"startTime":"0","endTime":"0","summary":" $银诺医药-B(02591)$ (02591.HK)公布招股结果，香港公开发售接获5,341.66倍认购，一手(200股)中签率0.5%。国际发售录得10.67倍认购。发售价18.68港元，集资净额6.35亿港元元。股份预期今日(15日)挂牌。银诺医药为亚洲第一家及全球第三家商业化原研人源长效胰高血糖素样肽-1(GLP-1)受体激动剂公司，是次拟全球发售3,655.64万股H股，香港公开发售占10%。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2b827bbc3b346a324213f3d186e2feaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"新股定价 | 银诺医药每股定价18.68港元，公开发售超购逾5340倍、一手中签率0.5%","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2559596058","title":"港股IPO动态：今日银诺医药上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2559596058","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559596058?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 06:15","pubTimestamp":1755209758,"startTime":"0","endTime":"0","summary":"今日银诺医药(2591.HK)上市，天岳先进(2631.HK)申购。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/15061552440392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["YANG","BK4614","HSCEI","HSTECH","02591"],"gpt_icon":0},{"id":"2559963122","title":"银诺医药-B(02591)暗盘暴涨270%引市场聚焦GLP-1赛道，派格生物医药-B(02565)价值洼地增长可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2559963122","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559963122?lang=zh_cn&edition=fundamental","pubTime":"2025-08-14 23:19","pubTimestamp":1755184741,"startTime":"0","endTime":"0","summary":"GLP-1赛道方兴未艾，获市场高度关注智通财经APP观察到，近日专注于GLP-1类药物研发的银诺医药-BIPO上市，其暗盘暴涨超270%，市值超324亿港币，而这反映的正是资本市场对于GLP-1类药物赛道以及内分泌疾病治疗市场的关注。实际上，在当下港市GLP-1类药物赛道中并不乏优质标的，派格生物医药-B便是其中的稀缺价值标的。而GLP-1RA因其可带来多重获益，在国内外各大指南中地位逐步提升，目前已被列为T2DM患者的一线治疗药物，维培那肽便是其中之一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2b827bbc3b346a324213f3d186e2feaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","GLP","02591","BK4144","02565","BK1161","399441","BK4590"],"gpt_icon":1},{"id":"2559762968","title":"银诺医药-B(02591.HK)：香港公开发售获5341.66倍认购","url":"https://stock-news.laohu8.com/highlight/detail?id=2559762968","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559762968?lang=zh_cn&edition=fundamental","pubTime":"2025-08-14 22:43","pubTimestamp":1755182583,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02591"],"gpt_icon":0},{"id":"2559957960","title":"银诺医药二次赴港IPO：一款减肥药可否撑起46亿估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2559957960","media":"中国基金报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559957960?lang=zh_cn&edition=fundamental","pubTime":"2025-08-14 20:28","pubTimestamp":1755174480,"startTime":"0","endTime":"0","summary":"银诺医药二次赴港IPO：一款减肥药可否撑起46亿估值？日前，港交所官网显示，银诺医药港股IPO申请获得受理，保荐人为中信证券和中金公司，通过18A规则申请上市。在2024年底首次递表失效后，仅隔6天，银诺医药又火速二次递表。招股书显示，2022年至2024年，银诺医药三年累计亏损达12.04亿元。招股书显示，2023年公司行政开支为2.56亿元，2024年缩减至8446万元，降幅达67%，其中，银诺医药的雇员福利2024年开支为4401.3万元，同比下滑81.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081420323497479f3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081420323497479f3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":0},{"id":"2559090956","title":"新股暗盘 | 银诺医药-B(02591.HK)暗盘收涨274.73% 每手赚10264港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559090956","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559090956?lang=zh_cn&edition=fundamental","pubTime":"2025-08-14 18:35","pubTimestamp":1755167758,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2b827bbc3b346a324213f3d186e2feaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02591"],"gpt_icon":0},{"id":"2559081951","title":"“减肥药市场新星”银诺医药-B港股暗盘涨近3倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2559081951","media":"钛媒体","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559081951?lang=zh_cn&edition=fundamental","pubTime":"2025-08-14 16:32","pubTimestamp":1755160320,"startTime":"0","endTime":"0","summary":"钛媒体App 8月14日消息，利弗莫尔证券显示，港股新股银诺医药-B暗盘涨超277%，报70.25港元。招股书显示，公司此次全球发售所得款项净额约达6.1亿元。其中，约90%将用于正在进行及计划中的临床试验以及核心产品依苏帕格鲁肽α的计划商业化上市；其余则作营运资金及一般公司用途。（科股宝播报）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081417323294e31fe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081417323294e31fe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["YANG","02591","BK4614"],"gpt_icon":0},{"id":"2559047930","title":"新股暗盘 | 银诺医药-B(02591)暗盘盘初涨265.10% 每手赚9904港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559047930","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559047930?lang=zh_cn&edition=fundamental","pubTime":"2025-08-14 16:18","pubTimestamp":1755159511,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B(02591)将于8月15日(周五)在香港挂牌。截至发稿，暗盘交易显示报价68.2港元，较招股价18.68港元上涨265.10%，每手200股，不计手续费，每手赚9904港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2b827bbc3b346a324213f3d186e2feaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591"],"gpt_icon":0},{"id":"1162391796","title":"老虎暗盘｜银诺医药-B涨超230%，中签一手赚超9800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162391796","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162391796?lang=zh_cn&edition=fundamental","pubTime":"2025-08-14 16:16","pubTimestamp":1755159372,"startTime":"0","endTime":"0","summary":"8月14日，生物制药公司银诺医药-B暗盘涨超230%，总市值超280亿港元；不计手续费，中签一手赚超8600港元；公司每股定价18.68港元，每手200股，将于8月15日（周五）正式挂牌交易。公司的管线目前包括正在开发用于治疗肥胖和超重及代谢功能障碍相关性脂肪性肝炎的核心产品依苏帕格鲁肽α，以及五款处于临床前阶段的候选药物。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2b827bbc3b346a324213f3d186e2feaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"银诺医药-B上市首日暗盘大涨，国产GLP-1药物前景看好","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2559310629","title":"银诺医药全员抽签，中签就是吃肉","url":"https://stock-news.laohu8.com/highlight/detail?id=2559310629","media":"郭二侠说财","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559310629?lang=zh_cn&edition=fundamental","pubTime":"2025-08-14 13:44","pubTimestamp":1755150276,"startTime":"0","endTime":"0","summary":"昨天下午16:00后各券商陆续公布银诺医药的中签结果，但详细信息要等今天暗盘交易结束后晚上22点港交所官方网站披露易发布新股配发结果公告。银诺医药招股定价18.68港元，一手市值3736港元。甲组乙组全部需要抽签，中签率比中慧生物还低。抽签和抽签不一样，肯定是认购的手数越多，中签的概率越高。例如打新一手抽签的中签概率是1%，100手可能就提高到20%了。根据港股IPO中签结果历史数据，这种策略在多数情况下是最优解。。。。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250814135114a6e55e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250814135114a6e55e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":1},{"id":"2559679542","title":"生物科技IPO冰火两重天：资本爱什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2559679542","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559679542?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 12:26","pubTimestamp":1755059206,"startTime":"0","endTime":"0","summary":"到8月12日收盘为止，上市以来表现最好的要数映恩生物，累计涨幅已达271.88%，应主要归因于其在ADC领域的优势。表现比较差的是提供临床阶段眼科疗法的拨康视云，以及维升药业，后者提供用于治疗儿童生长激素缺乏症的隆培促生长素，两家公司上市以来的股价累计跌幅分别为48.71%和28.92%。结语银诺医药的超购热潮与中慧生物上市后的亮眼表现，再次印证了市场对生物科技赛道，尤其是ADC等热门领域的强烈信心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081312273194e06e83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081312273194e06e83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADC","02591","BK4080","BK4231"],"gpt_icon":1},{"id":"2558649833","title":"减肥药概念股银诺医药-B(2591.HK)据报超购5364倍，超越蜜雪集团为今年超购王第二名！认购额涉资3700亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649833","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558649833?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 16:07","pubTimestamp":1754986023,"startTime":"0","endTime":"0","summary":"格隆汇8月12日｜减肥药概念股银诺医药-B(2591.HK)已于今日中午截飞。据悉，银诺医药的公开发售部分录得超额认购约5364倍，超越了今年3月初挂牌的蜜雪集团(2097.HK)(超购5257倍)，成为今年超购王第二名；认购额涉资约3700亿港元。据悉，银诺医药吸引约26万人入飞。银诺医药招股价为18.68港元，集资6.83亿港元。该股预计周五(15日)挂牌。中信证券(600030)、中金公司为保荐人。本文来自和讯财经，更多精彩资讯请下载“和讯财经”APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081216132894de6c44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081216132894de6c44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":0},{"id":"2558143586","title":"银诺医药-B(2591.HK)据报超购5364倍，为今年超购王第二名","url":"https://stock-news.laohu8.com/highlight/detail?id=2558143586","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558143586?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 15:34","pubTimestamp":1754984085,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1997245094.SGD","600030","LU0405327494.USD","BK1233","BK1587","06030","BK0196","SG9999002828.SGD","LU2148510915.USD","02591","LU2289578879.USD","LU1655091616.SGD","BK0028","02097","BK1616","BK1501","BK1521","BK0183","03908","LU1255011170.USD","LU1064130708.USD","BK1516","LU2495084118.USD","LU1997244956.HKD","LU1328615791.USD","BK0276","BK1564","LU1794554557.SGD","601995","LU1064131003.USD","BK0012","BK1147","LU0405327148.USD","LU1997245177.USD","LU1720050803.USD","BK0188"],"gpt_icon":0},{"id":"2557598086","title":"银诺医药港股IPO，预估一手中签率1%，甲组全部需要抽签","url":"https://stock-news.laohu8.com/highlight/detail?id=2557598086","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557598086?lang=zh_cn&edition=fundamental","pubTime":"2025-08-07 23:05","pubTimestamp":1754579100,"startTime":"0","endTime":"0","summary":"银诺医药本次IPO发行股份占全部股份比例的8%，按招股价上限18.68港元算，募资约6.83亿港元，5名基石投资者锁定7850万港元，流通盘6.04亿。按照20万人申购算，预估一手中签率1%，甲组全部需要抽签。银诺医药这次中签率非常低，性价比不高，可能会有少部分投资者放弃认购，打新乙组按1.5万人认购算，预估乙头抽签，乙三中签1手。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-08-07/doc-infketkk8686709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4614","02591","YANG","HSTECH","HSCEI"],"gpt_icon":1},{"id":"2557551256","title":"银诺医药(2591.HK)首日孖展超购逾136倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2557551256","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557551256?lang=zh_cn&edition=fundamental","pubTime":"2025-08-07 18:42","pubTimestamp":1754563377,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f90b8c761b5eafe71604f7f9c8d19537","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["HEXmain","02591"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":54,"code":"91000000","status":"200"}]}}